Madrigal Pharmaceuticals (MDGL) Leads Healthcare CapEx Growth Amid Elevated Price-to-Sales Valuation

gurufocus.com · 2026-09-02

On September 02, 2026, as the second-quarter earnings season wrapped up, Madrigal Pharmaceuticals, Inc. (MDGL) stood out with a remarkable 779.77% year-over-yea

Read the full story at gurufocus.com →